MedPath
HSA Approval

FUCIDIN OINTMENT 2%

SIN00722P

FUCIDIN OINTMENT 2%

FUCIDIN OINTMENT 2%

May 4, 1988

DKSH SINGAPORE PTE. LTD.

DKSH SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDKSH SINGAPORE PTE. LTD.
Licence HolderDKSH SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

OINTMENT

**Application** Fucidin® ointment is applied to the affected area 2–3 times daily, generally for a period of 7 days. It can be used with or without a covering dressing. Caution should be observed when applying Fucidin® ointment in the eye region as this preparation may cause irritation if it gets into the eye.

TOPICAL

Medical Information

**Indications** Fucidin® ointment is indicated for the treatment of skin infections caused by staphylococci, streptococci, Coryne-bacterium minutissimum, and other organisms sensitive to sodium fusidate. The most important indications being: ImpetigoBoilsCarbunclesParonychiaInfected woundsSycosis barbaeHidradenitisErythrasmaFolliculitis

**Contraindications** Hypersensitivity to the active substance or to any of the excipients.

D06AX01

fusidic acid

Manufacturer Information

DKSH SINGAPORE PTE. LTD.

LEO LABORATORIES LIMITED

Active Ingredients

SODIUM FUSIDATE

20 mg/g

Fusidic acid

Documents

Package Inserts

Fucidin Ointment PI.pdf

Approved: July 30, 2018

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FUCIDIN OINTMENT 2% - HSA Approval | MedPath